you are here:

Nippon India Pharma Fund - Direct Plan - Growth

  • Regular
  • Direct
Category : Sectoral/Thematic

Scheme Objective

To generate consistent returns by investing in equity,equity related of fixed income securities of Pharma and other associated companies.

Scheme Details

  • Fund manager(s)Sailesh Raj Bhan
  • Launch date – 02-Jan-2013
  • Expense ratio – 0.82% as declared on 31-Mar-2021 (category average is 1.27%)
  • Benchmark - S&P BSE Healthcare TRI
  • Min SIP amount - ₹
  • Min investment amount (one time- first time) - ₹
  • Min investment amount (addtional purchase) - ₹
  • Type : Open Ended Fund. You can invest any time in this fund.

Exit Load

Nippon India Pharma Fund - Direct Plan - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges.

Net Buy Price
Buy Date
Sell Date
  • Gross Profit
  • Exit Charges
  • Net Profit

Tax Rate

If sold after 1 year from purchase date, long term capital gain tax will be applicable. Current tax rate is 10%, if your total long term capital gain exceeds 1 lakh. Any cess/surcharge is not included.|If sold before 1 year from purchase date, short term capital gain tax will be applicable. Current tax rate is 15%. Any cess/surcharge is not included in the 15%.

Contact Details

Nippon Life India Asset Management Limited
Registered Office: 4th Floor, Tower A, Peninsula Business Park, Ganapatrao Kadam Marg, Lower Parel (W), Mumbai 400 013
Tel no.: 022-6808 7000/1860 266 0111
Fax no.: 022-6808 7097
Website.: nipponindiaim.com

Forum

+ See More